Illumina NextSeq 550Dx, REF: 20005715, CE, IVD

FDA Device Recall #Z-0854-2022 — Class II — February 22, 2022

Recall Summary

Recall Number Z-0854-2022
Classification Class II — Moderate risk
Date Initiated February 22, 2022
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Illumina, Inc.
Location San Diego, CA
Product Type Devices
Quantity 674 instruments

Product Description

Illumina NextSeq 550Dx, REF: 20005715, CE, IVD

Reason for Recall

There is a potential that the DNA sequence analyzer may short circuit shortly after disconnection and reconnection of circuit board or imaging module due to an insufficient reconnection of the ribbon cable. The short circuit results in the device being inoperable.

Distribution Pattern

US: PA, WA, CA, MI, FL, MD, AR, UT NC, Fl, IL, NE, NJ, TN, NY, IN, CO, GA, OK, TX, CT, SD, NM, VA, AL, LA, SC, WV, OR, IA, AZ, MN OUS: Australia Austria Belgium Chile China Denmark Finland France Germany Hungary Ireland Italy Japan Latvia Netherlands Norway Poland Portugal Romania Russian Federation Saudi Arabia Singapore Slovakia South Africa South Korea Spain Sweden Switzerland Turkey United Arab Emirates United Kingdom Vietnam

Lot / Code Information

Lot #s NDX550110 - NDX550843 ; UDI: (01)00816270020125

Other Recalls from Illumina, Inc.

Recall # Classification Product Date
Z-0884-2026 Class II Reagent Kits/ containing flow cells, components... Oct 28, 2025
Z-1977-2023 Class II MiSeq Dx Instrument, Catalog # M70101, containi... Apr 5, 2023
Z-1976-2023 Class II NextSeq 550Dx Instrument, Catalog # 20005715, c... Apr 5, 2023
Z-1260-2022 Class II illumina Model NextSeq 550 Dx REF 20005715 May 3, 2022
Z-1259-2022 Class II illumina REF DX-410-1001 Model: MiSeq Dx ill... May 3, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.